Illumina Stock Quote
$305.98 $7.54 2.5%
BATS BZX Real Time Price as of November 15, 2019, 4:00 p.m. EST View Interactive ILMN Charts

Illumina is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

News & Analysis: Illumina

The Fool has written over 400 articles on Illumina.


Market Moves



Better Buy: Illumina or Gilead Sciences?

We’re pitting off gene sequencing giant Illumina against giant biotech Gilead Sciences to see which company is the better buy for long-term investors.

What's Ahead for Healthcare in 2017?

A system that could revolutionize gene research and a first-in-class cancer therapy could be two of healthcare's biggest advances this year. Plus, UnitedHealth's earnings review, and a preview of Johnson & Johnson's earnings.

Interactive Chart